Search

A recent study from the Icahn School of Medicine at Mount Sinai explores the impact of kidney injury in end-stage liver disease and the role of liver transplantation in promoting kidney recovery. The research found that elevated levels of certain proteins were associated with kidney failure post-transplantation, indicating a link between inflammation and tubular cell loss. The study suggests that understanding this relationship could lead to therapeutic opportunities for promoting kidney recovery. For more information, the full article can be accessed for free at https://doi.org/10.3389/frtra.2024.1480383. [Extracted from the article]

A preprint abstract from medrxiv.org discusses the development of a deep learning model called the time-dependent LSTM (TdLSTM) to improve the prediction of chronic kidney disease (CKD) progression and patient outcomes. The model incorporates dynamic changes in the estimated glomerular filtration rate (eGFR) over time, which is a key indicator of kidney function. By capturing evolving patterns of CKD progression, the TdLSTM model provides more accurate predictions of patient outcomes and identifies distinct patient subtypes with varying progression rates. The study demonstrates the superiority of the TdLSTM model over existing models in predicting CKD progression. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

A study conducted by researchers from Diponegoro University in Semarang, Indonesia, focuses on hemodialysis, a treatment for kidney failure. The study highlights the prevalence of kidney failure, particularly in developing countries, and the need for dialysis. The researchers developed a method called molecularly imprinted membrane (MIM) for hemodialysis, which showed high selectivity for urea molecules. The study concludes that the selectivity of the MIM for urea is better than for creatinine and vitamin B12. For more information, readers can refer to the Indonesian Journal of Chemistry. [Extracted from the article]

A recent study conducted by McMaster University in Canada examined the end-of-life care provided to patients with kidney failure on maintenance dialysis. The study found that nephrologists and primary care physicians primarily manage outpatient care in the last year of life for these patients. The study also identified three patterns of care: a primary care, nephrology, and palliative care triad; a primary care and nephrology dyad; and a non-primary care pattern. The research suggests that further investigation is needed to determine the most optimal model of care for these patients. [Extracted from the article]

A recent study conducted by researchers at Sorbonne Universite in Paris, France, has provided new insights into Dent's disease, a rare X-linked recessive inherited renal disorder that primarily affects young males and often leads to end-stage renal failure. The disease is caused by mutations in the gene encoding ClC-5, a protein involved in reabsorbing filtered plasma proteins in the renal proximal tubule. The study aimed to understand the mechanisms linking the dysfunction of the proximal tubule to chronic kidney disease in Dent's disease type 1. The researchers also highlighted some potential urinary biomarkers for the disease. For more information, the full article can be accessed for free at the Genes journal website. [Extracted from the article]

This article discusses a new automated workflow for segmenting cysts in histological images of Autosomal Dominant Polycystic Kidney Disease (ADPKD). The workflow utilizes a neural network called the Segment Anything Model (SAM) and eliminates the need for manual annotations or preliminary training phases. The researchers applied this method to sequential histology images of ADPKD in mice and found a notable increase in the proportion of diseased tissue over time. The workflow outperformed existing tools and is publicly accessible for use in histological studies. However, it is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

A recent study conducted in Maharashtra, India aimed to understand the causes and histopathological features associated with renal failure. The study analyzed 650 adult autopsies over three years and found that acute febrile illness was the most common cause of acute renal failure. The majority of cases were from medical units, with a male predominance and a short hospital stay. The study identified several characteristic histopathological features in the kidney, which can aid in determining the cause of death. The researchers concluded that autopsy findings of the kidney are valuable and warrant further investigation. [Extracted from the article]

A recent research article from North Khorasan University of Medical Sciences explores the association between bacteria and urinary stones in patients with urolithiasis. The study highlights the rising prevalence of urolithiasis worldwide and the potential role of bacteria in stone recurrence. The article discusses the relationship between urinary tract infections (UTIs) and urolithiasis, as well as the formation of bacterial biofilms in UTIs. The research emphasizes the importance of considering various risk factors, including the presence of bacteria, in the treatment of patients with infectious stones. [Extracted from the article]

A recent study conducted by researchers at the University of the Witwatersrand in Johannesburg, South Africa, examined the patency rates of Spiral Flow grafts in hemodialysis patients. The study found that these grafts, which mimic physiological blood flow, had acceptable patency rates in patients with end-stage renal failure. However, the presence of certain comorbidities, such as hypertension, diabetes, and HIV, may affect the patency rates. This research provides valuable insights into vascular access for hemodialysis and may help improve treatment options for patients. [Extracted from the article]

A recent report from researchers at the University of Leicester discusses the treatment of immunoglobulin A nephropathy (IgAN), a kidney disease that often leads to kidney failure. The researchers argue that IgAN should be treated as both a chronic kidney disease and an immunological disease. They highlight several agents that have received approval for the treatment of IgAN, including budesonide and sparsentan, and mention other agents that are being investigated. The researchers suggest that combination treatments may be more effective in halting the progression of IgAN and call for more trials to develop a comprehensive treatment strategy. [Extracted from the article]

A recent report from Kunming Medical University in the People's Republic of China discusses a case of idiopathic nodular glomerulosclerosis in a 49-year-old male patient with a history of long-term smoking. The patient experienced renal insufficiency and proteinuria, and a renal biopsy revealed nodular glomerulosclerosis. Treatment with angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker drugs resulted in a decrease in albuminuria and stable renal function. The report also includes a retrospective analysis of 122 cases of idiopathic nodular glomerulosclerosis reported between 1999 and August 2023. This research has been peer-reviewed and provides valuable insights into this condition. [Extracted from the article]

Researchers from Mahidol University have conducted a study to investigate the impact of protein-bound uremic toxins (PBUTs) on microvascular function using an organ-on-a-chip (OOC). The study found that chronic exposure to p-cresol (PC), a type of PBUT, resulted in significant vascular leakage and decreased endothelial viability. PC also induced inflammatory responses and increased monocyte adhesion to endothelial surfaces. The findings suggest that PC accumulation is detrimental to endothelial cells during kidney insufficiency. This research provides valuable insights into the effects of PBUTs on the vasculature and highlights the importance of studying these toxins in a more realistic microenvironment. [Extracted from the article]

A recent study conducted by researchers at Thomas Jefferson University Sidney Kimmel Medical College provides new insights into IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide. The study highlights the pathogenesis of IgAN, which involves the activation and proliferation of mesangial cells, inflammatory cell recruitment, complement activation, and podocyte damage. Diagnosis of IgAN requires a biopsy interpreted by the Oxford criteria, and biomarkers such as proteinuria, reduced GFR, hypertension, and pathology can predict adverse outcomes. The mainstay of therapy for IgAN is supportive care, including lifestyle modifications and medication interventions. Immunosuppression may be considered for high-risk patients, but the use of corticosteroids and other immunosuppressants carries a high risk of side effects. Ongoing research is focused on B-cell inhibition and complement inhibition as potential treatment strategies. [Extracted from the article]

A new report published by the Renal Research Institute explores a novel method of hemodialysis called allo-hemodialysis (alloHD). This method involves the blood of a patient with kidney failure flowing through the dialyzer's dialysate compartment counter-currently to the blood of a healthy subject. The researchers developed a mathematical model and built a prototype machine to test the effectiveness of alloHD. Experiments using the prototype showed promising results, indicating the potential for future in vivo studies in animals. This research aims to address the lack of access to affordable renal replacement therapy for patients with end-stage kidney disease. [Extracted from the article]

Researchers from Sojo University in Kumamoto, Japan have conducted a study on the progression of renal failure in chronic kidney disease (CKD) mice. The study focused on the role of 7-phenylheptanoic acid (PH) and its hydroxypropyl b-cyclodextrin (HPbCD) complex formulation in suppressing the production of uremic toxins and slowing down renal failure. The researchers found that prophylactic oral administration of the PH-HPbCD complex formulation reduced circulating uremic toxins and attenuated the deterioration of renal function and tubulointerstitial fibrosis in CKD mice. These findings suggest that PH-HPbCD may have implications for preventing or managing CKD, particularly in early-stage disease. [Extracted from the article]

A patent has been issued to Broad Institute Inc. for agents that can reverse toxic proteinopathies, which are diseases caused by genetic mutations resulting in the accumulation of misfolded proteins in cells. The patent describes the identification of a compound called BRD-4780, which has been found to effectively treat MUC1-associated kidney disease and other toxic proteinopathies. The compound works by reducing the accumulation of mutant proteins in the early secretory pathway of cells. This patent provides potential methods for treating uromodulin kidney disease and includes various claims related to the administration of the compound. [Extracted from the article]

A patent application has been submitted for a system and method that aims to improve home dialysis device maintenance. The system includes a health service provider computing system that collects information from the at-home dialysis device and other devices, detects alarms or failures, and suggests potential solutions based on the collected information. Machine learning models are used to train the system and enhance its performance. This technology has the potential to enhance the health outcomes and quality of life for patients undergoing dialysis at home. The patent application provides more information and claims regarding the system and methods described. [Extracted from the article]

A study conducted at the South China University of Technology has developed a new strategy for the diagnosis of early kidney injury using pH-responsive luminescent gold nanoparticles. The researchers created nanoparticles that can self-assemble in the kidney's acidic microenvironment, allowing for sensitive and long-term imaging of different stages of kidney injury. The nanoparticles were able to differentiate between early and late-stage kidney injury within 10 minutes of injection and showed promise for monitoring the progression of kidney dysfunction. This research opens up possibilities for early-stage diagnosis of pH-related diseases. [Extracted from the article]

A new report discusses research findings on peritoneal dialysis (PD) as a treatment for advanced kidney failure. The study aimed to investigate the correlation between the level of 8-hydroxy-2'-deoxyguanosine (8OHDG), a marker of oxidative stress, in the peritoneal solution of patients undergoing PD and various factors such as peritoneal equilibration test (PET), dialysis adequacy (Kt/V), underlying diseases, serum ferritin, and albumin levels. The results showed that 8OHDG levels had significant associations with PET and underlying hypertension (HTN), suggesting that it could be used to evaluate the function of the peritoneum in patients undergoing PD. The research has been peer-reviewed and published in the Iranian Journal of Kidney Diseases. [Extracted from the article]

Researchers from the First Affiliated Hospital of Chongqing Medical University in China have published a case report on a 49-year-old female patient with multiple myeloma and renal failure who developed dysuria. The patient was found to have a urinary tract infection caused by multidrug-resistant Aeromonas caviae. After receiving treatment with piperacillin-tazobactam for seven days, her symptoms improved significantly. This case report aims to contribute to the diagnosis and management of Aeromonas caviae cystitis. [Extracted from the article]

A recent study conducted in Fukuoka, Japan, has developed a novel prediction model for end-stage kidney disease (ESKD) in individuals with chronic kidney disease (CKD). The researchers found that serum bilirubin levels were strong predictors of CKD progression to ESKD. The prediction model, which incorporates serum bilirubin levels along with other variables such as eGFR, proteinuria, age, and diabetes, demonstrated excellent predictive performance and calibration. This study provides valuable insights for improving patient outcomes and accurately predicting ESKD in individuals with CKD. [Extracted from the article]

A recent study conducted at Lillebaelt Hospital in Vejle, Denmark, explored the role of genomic disorders in chronic kidney failure of undetermined etiology (uKF) in patients aged 50 or younger. The researchers screened 172 patients and identified causative copy number variations (CNVs) in 12 patients, providing a kidney diagnosis for three patients who developed kidney failure before the age of 18. Whole-genome sequencing also revealed causative genetic diagnoses in four additional patients. The study highlights the prevalence of genomic disorders in uKF and suggests the need for further research to clarify the causal role of these disorders in kidney disease. [Extracted from the article]

A recent study conducted by Duke University examined the safety of using the medication acitretin in patients with end-stage renal disease (ESRD) who are undergoing hemodialysis (HD). Acitretin is commonly used to treat severe psoriasis and keratinocyte carcinoma, but it is contraindicated in ESRD patients on HD. The study found that while adverse effects were common, they were not a frequent cause of treatment discontinuation. There was also no association between acitretin treatment and hospital admissions or mortality. The researchers concluded that acitretin may be safely used in patients receiving HD, with close monitoring of certain liver enzymes. [Extracted from the article]

Researchers at Johns Hopkins University have conducted a study on the progression of kidney disease. The study analyzed proteins and metabolites in a cohort of 1,708 individuals with chronic renal insufficiency over a period of 9.5 years. The researchers identified 139 modules of correlated proteins and metabolites that were associated with kidney disease progression and kidney failure. The study demonstrates the importance of integrating the proteome and metabolome in understanding the pathophysiology of kidney disease. [Extracted from the article]

A study conducted at Sree Balaji Medical College and Hospital explores the use of glycine 1.5% as an irrigation fluid for transurethral resection of the prostate (TURP) in patients with severe renal insufficiency. TURP syndrome, a rare but serious complication characterized by fluid absorption, can lead to life-threatening complications. The study highlights the lack of research on the choice of irrigation fluid for patients with severe renal insufficiency and discusses the case of a 68-year-old male who developed TURP syndrome with 1.5% glycine as irrigation fluid. The researchers emphasize the need to consider alternative irrigation fluids for patients with severe renal insufficiency. [Extracted from the article]

A preprint abstract discusses the impact of competing risks on the performance of prognostic models in the context of kidney transplantation. The study included 10,546 adult kidney transplant recipients from 10 countries and developed prediction models for long-term kidney graft failure. The models were assessed for their development, stability, discrimination, calibration, overall fit, and generalizability. The results showed that competing and non-competing risks models performed similarly in predicting long-term kidney graft failure, but the importance of considering competing risks may vary depending on the clinical scenario and population. [Extracted from the article]

A recent research study conducted at Chia Nan University of Pharmacy and Science in Tainan, Taiwan, has explored a new method for detecting kidney failure using a zinc-doped nanocone and the creatinine biomarker. The study utilized density functional theory calculations to optimize the creatinine adsorbate and the ZnCone adsorbent. The research found that the Zn-doped atom effectively interacted with the creatinine biomarker, allowing for successful detection of kidney failure. This study has been peer-reviewed and provides valuable insights into the potential of this detection platform. [Extracted from the article]

A case report from Wuhan University in Hubei, China, describes a 32-year-old male patient with sarcoidosis, a rare disease that affects the lungs, lymph nodes, skin, eyes, and kidneys. The patient presented with joint pain and was diagnosed with uncorrectable hypercalcemia, a condition characterized by high levels of calcium in the blood. The report highlights the effectiveness of glucocorticoid treatment in improving and preserving renal function in the patient. The researchers emphasize the importance of actively treating sarcoidosis to prevent organ damage. This research has been peer-reviewed and published in Experimental and Therapeutic Medicine. [Extracted from the article]

A recent study conducted at the University Putra Malaysia explored the experiences of patients with kidney failure undergoing haemodialysis in three private hospitals in Malaysia. The study found that patients reported emotional distress, life limitations, financial burdens, knowledge deficits, and varying perceptions of the haemodialysis treatment. Coping strategies used by patients included body image changes, financial assistance, social support, and hope. The researchers concluded that nurses should focus on mitigating emotional distress, increasing knowledge about kidney failure, and improving perception of haemodialysis treatment, as well as providing social support to help patients cope. [Extracted from the article]

A recent research study conducted by Johns Hopkins University Bloomberg School of Public Health has found that the integration of proteomic and metabolomic modules can help identify functions that are important in kidney disease progression. The study analyzed proteins and metabolites in the Chronic Renal Insufficiency Cohort Study and identified 139 modules of correlated proteins and metabolites. Two modules, consisting of 236 proteins and 82 metabolites, were found to be associated with both chronic kidney disease progression and kidney failure. The study highlights the importance of integrating proteomic and metabolomic data in understanding kidney disease. [Extracted from the article]

A digital tool called KDpredict, developed by researchers at the University of Calgary in collaboration with international partners, can accurately predict the risks of kidney failure and death in adults with moderate to severe kidney disease. The tool uses health data from nearly 100,000 patients with chronic kidney disease to create a predictive algorithm and digital dashboard. KDpredict calculates one-to five-year risks of kidney failure and death using variables such as age, sex, kidney function, and protein levels in the blood. The tool has the potential to improve treatment decisions and increase awareness of associated health risks. [Extracted from the article]

A recent study conducted by the University of Arizona College of Medicine examined the safety of using acitretin, a medication commonly used for severe psoriasis and keratinocyte carcinoma chemoprevention, in patients with end-stage renal disease on hemodialysis. While acitretin is contraindicated in these patients, the study found that in certain clinical scenarios, the benefits of acitretin may outweigh the potential risks. The researchers identified 24 end-stage renal disease patients on hemodialysis who were taking acitretin and found that adverse effects were common but did not frequently lead to discontinuation of the medication. The study also found no association between acitretin use and hospital admissions or mortality. However, there were statistically significant increases in ALP and total bilirubin levels when patients were on acitretin and dialysis compared to baseline. Based on these preliminary findings, the researchers suggest that acitretin may be safely used in patients receiving hemodialysis with close monitoring of ALP and bilirubin levels. [Extracted from the article]

A study conducted by researchers at Changhua Christian Hospital in Taiwan has found a link between age, kidney failure, and eye diseases, particularly cataracts. The study included 127,561 cancer-free volunteers aged 30 to 70 years and collected information on kidney failure, age, and eye diseases through questionnaires. The results showed that kidney failure and older age were independently associated with a higher risk of eye diseases, with a significant interaction between kidney failure and age on cataracts. The researchers suggest that there may be a bidirectional relationship between cataracts and kidney failure, especially in individuals below 50 years, highlighting the need for screening for both conditions in younger adults. [Extracted from the article]

A report from RWTH Aachen University Hospital in Germany discusses the findings of research on immunoglobulin A nephropathy (IgAN), a kidney disease. The research highlights the role of the lectin pathway in IgAN and its potential as a target for therapy. The study suggests that the lectin pathway may contribute to kidney injury and fibrosis in IgAN, and inhibiting this pathway could be a potential treatment option. The research is supported by the Omeros Corporation and has been peer-reviewed. [Extracted from the article]

A recent study conducted at the Department of Psychiatry and Behavioral Sciences examined the interplay between anxiety, depression, sleep quality, and socioeconomic factors in Somali hemodialysis patients with kidney failure. The study involved 200 participants receiving hemodialysis treatment for over 3 months. The findings revealed that a significant number of patients experienced depressive symptoms and poor sleep quality, which were correlated with anxiety and depression. The researchers emphasized the importance of early identification and appropriate management of these psychological disturbances to enhance patients' overall quality of life. [Extracted from the article]

The patent application by Astute Medical Inc. discusses methods and compositions for assessing the potential benefits of continued renal replacement therapy (RRT) for individuals with acute kidney injury (AKI). The invention involves measuring specific biomarkers, such as CCL14 and KLK14, in body fluid samples to determine the likelihood of benefiting from continued RRT. The goal is to improve clinical decision-making and avoid unnecessary or delayed RRT, ultimately benefiting individuals with renal injury or failure. [Extracted from the article]

Researchers from the University of Texas Southwestern Medical Center have conducted a quality control study of a modified aptamer assay called SomaScan v.4.0. The assay measures approximately 5000 proteins and was evaluated in patients with kidney failure on dialysis. The study found that the SomaScan assay had excellent technical variability and low within-subject short-term variability. The researchers expect that SomaScan will provide novel and reproducible information for patients with kidney failure on dialysis. [Extracted from the article]

A research study conducted at Shri Sathya Sai Medical College and Research Institute focused on the assessment of metabolic acidosis in patients with renal failure. The study aimed to evaluate the metabolic acidosis using the calculation of delta gap, which is a quick and short equation that can be easily calculated at the bedside. The researchers found that high anion gap metabolic acidosis was seen in 65% of the cases, while non-anion gap metabolic acidosis was also observed in 33% of the cases. The study concluded that early identification of the type and causative mechanism of metabolic acidosis in renal failure patients may help decrease morbidity and mortality. [Extracted from the article]

A study conducted at Xuyi People's Hospital in Jiangsu, China, has found that Panax notoginseng saponins (PNS) can effectively inhibit renal interstitial fibrosis (RIF) in rats with renal failure. The researchers created different groups of models to assess the effects of PNS on RIF, and found that PNS significantly inhibited the changes associated with renal interstitial fibrosis. This inhibition was related to decreased expressions of TLR4 and NF-xB, and the researchers concluded that PNS inhibits the activity of the TLR4/NF-xB signaling pathway to down-regulate the expressions of fibrosis-related factors. This research has been peer-reviewed and provides valuable insights into the potential use of PNS in treating renal interstitial fibrosis. [Extracted from the article]

A preprint abstract from medrxiv.org discusses the economic effects of kidney failure treatment on the household welfare of patients on dialysis in Buea and Bamenda, Cameroon. The study found that the direct and indirect costs of kidney failure treatment have a significant negative impact on the household income of patients. The mean annual household expenditure was 1,547,729FCFA, while the mean yearly total cost of kidney failure treatment was 2,137,556FCFA. The study suggests that kidney disease screening and prevention programs, as well as health insurance schemes and universal health coverage, should target patients on dialysis to alleviate the financial burden. [Extracted from the article]

Researchers at Ferdowsi University of Mashhad in Iran have conducted a study on the computational design of high affinity molecularly imprinted polymer (MIP) biosensors for the selective detection of renal failure biomarkers. The study used density functional theory (DFT) and topological analysis to optimize the design of the biosensors. The researchers found the optimal molar ratio, solvent, and cross-linking agent for MIP preparation, and demonstrated the high affinity of the MIPs for the target biomarkers. This study provides a useful protocol for predicting optimal conditions and reducing the time and cost of MIP preparation. [Extracted from the article]

A recent study conducted by researchers at the University Health Network in Toronto, Canada, found that African, Caribbean, and Black (ACB) Canadian patients with advanced kidney failure have less knowledge about renal transplantation compared to White Canadian patients. The study used the Knowledge Assessment of Renal Transplantation (KART) questionnaire to assess transplant-related knowledge. The researchers also found that distrust in the kidney allocation system may contribute to the differences in knowledge between ACB and White patients. These findings highlight the need for targeted interventions to improve transplant-related knowledge and address distrust among ACB communities. [Extracted from the article]

A recent study conducted by Johns Hopkins University School of Medicine explored the implementation of the kidney failure risk equation (KFRE) in nephrology clinics. The study found that the integration of KFRE scores into the electronic health record at Johns Hopkins Medicine led to an increase in documentation of these scores over time. However, there was variability in the use of KFRE for clinical decisions among providers, and there was limited knowledge about its utilization. The study suggests that education on appropriate interpretations of KFRE scores may help maximize their utility. [Extracted from the article]

A recent study conducted by researchers at the University of Gothenburg Sahlgrenska Academy in Sweden examined the long-term survival rates of kidney transplants in men and women. The study analyzed data from a quality registry that included all kidney transplant patients from 1965 to 2017. The findings revealed that women had shorter graft survival than men during the most recent observation period (2006-2017). The study also found that biopsy-proven rejections were more common in women. This research provides valuable insights into sex-specific trends in kidney graft survival and highlights the need for further investigation into potential factors contributing to these differences. [Extracted from the article]